Parexel management changes
Parexel COO Carl Spalding will retire effective June 30; the COO position will remain unfilled for the foreseeable future, the contract research organization said. President-Clinical Research Services Michael Woehler is promoted to Exec VP, and President-Perceptive Informatics Mark Goldberg will take Woehler's former title; Goldberg will also continue to oversee perceptive informatics. Kurt Brykman is promoted to president-consulting and medical marketing services...
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.